Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

When FDA approved the first carotid stent, in August 2004, many industry analysts suggested that the market for such devices could reach $1 billion by 2010. Since that time, however, forecasts have ...

Targeting the stent-manufacturing industry, this fully integrated system uses an integral linear-rotary design, offering two to five times higher throughput than screw-based or more traditional ...

November 24, 2011 (Rockville, Maryland and Detroit, Michigan) — The US Food and Drug Administration (FDA) has approved the Promus Element Plus everolimus-eluting chromium platinum coronary stent ...

Cardiac stents have transformed the landscape of cardiovascular medicine, providing a less invasive and highly effective means to treat coronary artery disease. What is a stent? A cardiac stent is a ...

Promising technology developed by a University Hospitals doctor that looks to decrease discomfort in kidney stone patients achieved a major milestone in the path toward mass commercialization with its ...

CHICAGO (Reuters) - U.S. health insurers appear to be shrugging off a controversial new study that found treatment with drugs is just as good as more expensive stenting for chronic chest pain. The ...

Around 2.3 million people in the UK have coronary artery disease. The condition is caused by a build-up of fatty substances in the coronary arteries, at locations known as lesions. This can reduce ...